Forward together with innovation:The importance of policy making in the era of personalised medicine – 3-4 December 2019, Brussels, Belgium

The ​Belgian ​capital ​has ​been ​chosen ​to ​host ​the ​event ​as ​the ​new ​Parliament ​will ​be ​in ​place ​after ​the ​summer ​elections, ​while ​a ​new ​European ​Commission ​will ​be ​in ​the ​process ​of ​being ​formed, ​ready ​to ​formally ​move ​into ​the ​Berlaymont ​not ​long ​afterwards.
The ​event ​will ​be ​held ​under ​the ​auspices ​of ​the ​Finnish ​Presidency ​of ​the ​EU, ​which ​will ​run ​from ​July ​to ​December. The ​Congress ​is ​in ​a ​focused ​format ​to ​allow ​concrete ​issues ​to ​be ​tackled ​and ​to ​have ​a ​dialogue ​with ​our ​policy ​makers. Essentially, ​this ​3rd ​annual ​Congress ​will ​provide ​the ​ideal ​space ​to ​allow ​for ​a ​meeting ​of ​minds ​and ​expertise ​and ​represent ​a ​vital ​opportunity ​for ​top-level ​discussion ​and the ​formulation ​of ​real ​action ​plans, ​for ​example ​in ​the ​area ​of ​translational ​research.
Congress ​will ​showcase ​different ​objectives ​which ​both ​the ​public ​and ​private ​sector ​can ​support, ​with ​a ​view ​to ​allowing ​the ​EU ​to ​present ​a ​common ​objective. Innovation ​and ​the ​incentives ​for ​it ​are ​key ​to ​health ​and ​wealth ​in ​the ​current ​EU-28 ​(and ​will ​be ​even ​more ​important ​after ​the ​UK ​leaves). It ​also ​encourages ​investment ​from ​outside ​of ​the ​EU, ​which ​is ​good ​for ​business ​and ​jobs. It ​is ​clear ​that ​innovation ​needs ​to ​soar ​to ​new ​heights, ​and ​be ​implemented ​and ​integrated, ​for ​the ​bene ​t ​of ​EU ​citizens.

More info at: http://ec.europa.eu/research/index.cfm?pg=events&eventcode=1B0CD48E-B3A4-98C7-4B0F92BE78421672


Top